Author
Listed:
- Johannes Zuber
(Cold Spring Harbor Laboratory, 1 Bungtown Road
Research Institute of Molecular Pathology (IMP), Dr. Bohr-Gasse 7, A-1030 Vienna, Austria)
- Junwei Shi
(Cold Spring Harbor Laboratory, 1 Bungtown Road
Molecular and Cellular Biology Program, Stony Brook University)
- Eric Wang
(Cold Spring Harbor Laboratory, 1 Bungtown Road)
- Amy R. Rappaport
(Cold Spring Harbor Laboratory, 1 Bungtown Road
Watson School of Biological Sciences, 1 Bungtown Road)
- Harald Herrmann
(Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, A-1090 Vienna, Austria)
- Edward A. Sison
(Johns Hopkins University School of Medicine)
- Daniel Magoon
(Johns Hopkins University School of Medicine)
- Jun Qi
(Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, Massachusetts 02115, USA)
- Katharina Blatt
(Medical University of Vienna, A-1090 Vienna, Austria)
- Mark Wunderlich
(Cincinnati Children’s Hospital Medical Center)
- Meredith J. Taylor
(Cold Spring Harbor Laboratory, 1 Bungtown Road)
- Christopher Johns
(Cold Spring Harbor Laboratory, 1 Bungtown Road)
- Agustin Chicas
(Cold Spring Harbor Laboratory, 1 Bungtown Road)
- James C. Mulloy
(Cincinnati Children’s Hospital Medical Center)
- Scott C. Kogan
(University of California at San Francisco)
- Patrick Brown
(Johns Hopkins University School of Medicine)
- Peter Valent
(Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, A-1090 Vienna, Austria
Medical University of Vienna, A-1090 Vienna, Austria)
- James E. Bradner
(Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, Massachusetts 02115, USA)
- Scott W. Lowe
(Cold Spring Harbor Laboratory, 1 Bungtown Road
Watson School of Biological Sciences, 1 Bungtown Road
Howard Hughes Medical Institute, 1 Bungtown Road)
- Christopher R. Vakoc
(Cold Spring Harbor Laboratory, 1 Bungtown Road)
Abstract
Brd4 target in acute myeloid leukaemia In an RNAi screen targeting chromatin regulators, Vakoc and colleagues find that maintenance of acute myeloid leukaemia (AML) requires Brd4, which binds to acetylated histones to influence gene transcription. Brd4 regulates expression of the oncogene Myc and a Myc-driven gene-expression program that permits leukaemia cells to self-renew. JQ1, a small molecule that inhibits Brd4 function, has anti-leukaemic effects in a mouse model and inhibits the proliferation of primary human AML cells, suggesting a therapeutic approach in patients with AML.
Suggested Citation
Johannes Zuber & Junwei Shi & Eric Wang & Amy R. Rappaport & Harald Herrmann & Edward A. Sison & Daniel Magoon & Jun Qi & Katharina Blatt & Mark Wunderlich & Meredith J. Taylor & Christopher Johns & A, 2011.
"RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia,"
Nature, Nature, vol. 478(7370), pages 524-528, October.
Handle:
RePEc:nat:nature:v:478:y:2011:i:7370:d:10.1038_nature10334
DOI: 10.1038/nature10334
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Stella Amanda & Tze King Tan & Jolynn Zu Lin Ong & Madelaine Skolastika Theardy & Regina Wan Ju Wong & Xiao Zi Huang & Muhammad Zulfaqar Ali & Yan Li & Zhiyuan Gong & Hiroshi Inagaki & Ee Yong Foo & B, 2022.
"IRF4 drives clonal evolution and lineage choice in a zebrafish model of T-cell lymphoma,"
Nature Communications, Nature, vol. 13(1), pages 1-16, December.
- Yansheng Zhai & Xiaoyan Huang & Keren Zhang & Yuchen Huang & Yanlong Jiang & Jingwei Cui & Zhe Zhang & Cookson K. C. Chiu & Weiye Zhong & Gang Li, 2022.
"Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling,"
Nature Communications, Nature, vol. 13(1), pages 1-12, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:478:y:2011:i:7370:d:10.1038_nature10334. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.